Xilian Bai
- Microbiology top 0.5%
- Bacterial Infections and Vaccines 38
- Epidemiology top 5%
- Pneumonia and Respiratory Infections 32
- Virology and Viral Diseases 8
- Influenza Virus Research Studies 5
- Respiratory viral infections research 3
- Infective Endocarditis Diagnosis and Management 2
- Health top 10%
-
- SARS-CoV-2 and COVID-19 Research 2
-
- Complement system in diseases 3
- Co-authors
- Ray BorrowJamie FindlowJay LucidarmeShamez LadhaniNick AndrewsHelen CampbellHelen FindlowMary Ramsay
- Cited by
- MicrobiologyEpidemiologyHealth
- Journals
- New England Journal of Medicine (2 papers)PLoS ONE (3 papers)Clinical Infectious Diseases (4 papers)
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
Xilian Bai
36 papers receiving 899 citations
Peers
Comparison fields: 5 of 60
- Microbiology 748
- Epidemiology 750
- Health 105
- Endocrinology 30
- Infectious Diseases 84
Countries citing papers authored by Xilian Bai
This map shows the geographic impact of Xilian Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xilian Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xilian Bai more than expected).
Fields of papers citing papers by Xilian Bai
This network shows the impact of papers produced by Xilian Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xilian Bai. The network helps show where Xilian Bai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xilian Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 18 | |
| 5 | 2023 | 9 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 27 | |
| 8 | 2019 | 3 | |
| 9 | 2019 | 31 | |
| 10 | 2018 | 37 | |
| 11 | 2016 | 61 | |
| 12 | 2016 | 35 | |
| 13 | 2015 | 16 | |
| 14 | 2015 | 1 | |
| 15 | 2015 | 129 | |
| 16 | 2014 | 16 | |
| 17 | 2012 | 49 | |
| 18 | 2011 | 84 | |
| 19 | 2011 | 9 | |
| 20 | 2010 | 27 |
About Xilian Bai
Xilian Bai is a scholar working on Microbiology, Epidemiology and Health, having authored 38 papers that have together received 924 indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (38 papers), Pneumonia and Respiratory Infections (32 papers), Virology and Viral Diseases (8 papers), Influenza Virus Research Studies (5 papers), Respiratory viral infections research (3 papers), Complement system in diseases (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Infective Endocarditis Diagnosis and Management (2 papers). The work is most often cited by research in Microbiology (748 citations), Epidemiology (750 citations) and Health (105 citations). Xilian Bai has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Ray Borrow, Jamie Findlow, Jay Lucidarme, Shamez Ladhani, Nick Andrews, Helen Campbell, Helen Findlow, Mary Ramsay, Sydel R. Parikh and Elizabeth Miller. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.